Pregnancy Category C. There are no available studies in pregnant women. ISMN should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether ISMN is excreted in breast milk. Exercise caution when administering Montra to breastfeeding women.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
